×

Do you want to link to this External Site and leave Amgen.co.kr?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this Amgen Site and leave Amgen.co.kr?

YOU ARE NOW LEAVING AMGEN KOREA'S WEB SITE. Amgen Korea takes takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

otezla

Otezla® Tablet

  • Product Name (Korean) 오테즐라®정 (아프레밀라스트)
  • Product Name (English) Otezla® Tablet (Apremilast)
  • Active Ingredient (Korean) 아프레밀라스트
  • Active Ingredient (English) Apremilast
  • API content 10mg, 20mg, 30mg
  • Excipients Lactose anhydrous, Microcystaline cellulose, Croscarmellose Sodium, Magensium Stearate, OpadryII Pink(10mg), OpadryII Brown(20mg), OpadryII Beige(30mg)
  • Treatment Psoriatic Arthritis, Psoriasis
  • Indications
    1. Psoriatic Arthritis: The treatment of active psoriatic arthritis (PsA) in adult patients who have had an inadequate response or who have been intolerant to a prior anti-rheumatic therapy (DMARD)
    2. Psoriasis: The treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
  • Otezla® Medication Guide